Polycystic kidney disease physical examination
|
Polycystic kidney disease Microchapters |
|
Differentiating Polycystic kidney disease from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic kidney disease physical examination On the Web |
|
American Roentgen Ray Society Images of Polycystic kidney disease physical examination |
|
Risk calculators and risk factors for Polycystic kidney disease physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: M. Khurram Afzal, MD [2], Serge Korjian,Yazan Daaboul
Overview
Patients with polycystic kidney disease usually are in discomfort. Physical examination of patients with polycystic kidney disease is usually remarkable for hypertension, jaundice, pallor, icteric sclera, palpable nodular hepatomegaly, palpable flank mass.
Physical Examination
Physical examination of patients with polycystic kidney disease is usually remarkable for hypertension, jaundice, pallor, icteric sclera, palpable nodular hepatomegaly, palpable flank mass.[1][2][3]
Appearance of the Patient
- Patients with polycystic kidney disease usually are in discomfort
Vital Signs
Skin
HEENT
- Icteric sclera
Neck
- Neck examination of patients with polycystic kidney disease is usually normal
Lungs
- Pulmonary examination of patients with polycystic kidney disease is usually normal
Heart
- Cardiovascular examination of patients with polycystic kidney disease is usually normal
Abdomen
Back
- Palpable mass in the flank
- Costovertebral angle tenderness
Genitourinary
- Genitourinary examination of patients with polycystic kidney disease is usually normal
Neuromuscular
- Neuromuscular examination of patients with polycystic kidney disease is usually normal
Extremities
- Pitting edema of the upper/lower extremities
References
- ↑ Gabow PA (1993). "Autosomal dominant polycystic kidney disease". N Engl J Med. 329 (5): 332–42. doi:10.1056/NEJM199307293290508. PMID 8321262.
- ↑ Torres VE, Harris PC, Pirson Y (2007). "Autosomal dominant polycystic kidney disease". Lancet. 369 (9569): 1287–301. doi:10.1016/S0140-6736(07)60601-1. PMID 17434405.
- ↑ Baker A, King D, Marsh J, Makin A, Carr A, Davis C, Kirby C (October 2015). "Understanding the physical and emotional impact of early-stage ADPKD: experiences and perspectives of patients and physicians". Clin Kidney J. 8 (5): 531–7. doi:10.1093/ckj/sfv060. PMC 4581379. PMID 26413277.